These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 1918971

  • 1. Anti-IgM-mediated growth inhibition of a human B lymphoma cell line is independent of phosphatidylinositol turnover and protein kinase C activation and involves tyrosine phosphorylation.
    Beckwith M, Urba WJ, Ferris DK, Freter CE, Kuhns DB, Moratz CM, Longo DL.
    J Immunol; 1991 Oct 01; 147(7):2411-8. PubMed ID: 1918971
    [Abstract] [Full Text] [Related]

  • 2. Protein kinase C activation blocks anti-IgM-mediated signaling BAL17 B lymphoma cells.
    Mizuguchi J, Ji YY, Nakabayaschi H, Huang KP, Beaven MA, Chused T, Paul WE.
    J Immunol; 1987 Aug 15; 139(4):1054-9. PubMed ID: 3038996
    [Abstract] [Full Text] [Related]

  • 3. B cell antigen receptor cross-linking triggers rapid protein kinase C independent activation of p21ras1.
    Harwood AE, Cambier JC.
    J Immunol; 1993 Nov 01; 151(9):4513-22. PubMed ID: 8409414
    [Abstract] [Full Text] [Related]

  • 4. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
    Padmore L, An S, Gunby RH, Kelly K, Radda GK, Knox KA.
    Cell Immunol; 1997 May 01; 177(2):119-28. PubMed ID: 9178638
    [Abstract] [Full Text] [Related]

  • 5. Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line.
    Lee JR, Koretzky GA.
    J Immunol; 1998 Aug 15; 161(4):1637-44. PubMed ID: 9712025
    [Abstract] [Full Text] [Related]

  • 6. A mutant of the WEHI-231 B lymphocyte line that is resistant to phorbol esters is still sensitive to antigen receptor-mediated growth inhibition.
    Haggerty HG, Monroe JG.
    Cell Immunol; 1994 Mar 15; 154(1):166-80. PubMed ID: 8118885
    [Abstract] [Full Text] [Related]

  • 7. Anti-Ig-mediated proliferation of human B cells in the absence of protein kinase C.
    Francois DT, Katona IM, June CH, Wahl LM, Feuerstein N, Huang KP, Mond JJ.
    J Immunol; 1988 May 15; 140(10):3338-43. PubMed ID: 3129493
    [Abstract] [Full Text] [Related]

  • 8. Phorbol esters and dioctanoylglycerol block anti-IgM-stimulated phosphoinositide hydrolysis in the murine B cell lymphoma WEHI-231.
    Gold MR, DeFranco AL.
    J Immunol; 1987 Feb 01; 138(3):868-76. PubMed ID: 3027166
    [Abstract] [Full Text] [Related]

  • 9. CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C.
    Teng JM, Liu XR, Mills GB, Dupont B.
    J Immunol; 1996 May 01; 156(9):3222-32. PubMed ID: 8617944
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
    Pukac LA, Carter JE, Ottlinger ME, Karnovsky MJ.
    J Cell Physiol; 1997 Jul 01; 172(1):69-78. PubMed ID: 9207927
    [Abstract] [Full Text] [Related]

  • 11. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
    Scott DW, Livnat D, Whitin J, Dillon SB, Snyderman R, Pennell CA.
    J Mol Cell Immunol; 1987 Jul 01; 3(2):109-20. PubMed ID: 3509921
    [Abstract] [Full Text] [Related]

  • 12. Membrane IgM cross-linking is not coupled to protein kinase C translocation in WEHI-231 B lymphoma cells.
    Sarthou P, Henry-Toulmé N, Cazenave PA.
    Eur J Immunol; 1989 Jul 01; 19(7):1247-52. PubMed ID: 2668012
    [Abstract] [Full Text] [Related]

  • 13. Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells.
    Page DM, DeFranco AL.
    J Immunol; 1988 Jun 01; 140(11):3717-26. PubMed ID: 2836499
    [Abstract] [Full Text] [Related]

  • 14. Apoptotic cell death induced by anti-IgM antibody and phorbol esters is inhibited by interleukin-4 in human B lymphoma cell line MBC-1.
    Komada Y, Zhang XL, Zhou YW, Tanaka S, Higashigawa M, Ido M, Sakurai M.
    Cell Immunol; 1994 Dec 01; 159(2):280-93. PubMed ID: 7994760
    [Abstract] [Full Text] [Related]

  • 15. Cross-linking of surface IgM or IgD causes differential biological effects in spite of overlap in tyrosine (de)phosphorylation profile.
    Alés-Martinez JE, Scott DW, Phipps RP, Casnellie JE, Kroemer G, Martinez C, Pezzi L.
    Eur J Immunol; 1992 Mar 01; 22(3):845-50. PubMed ID: 1547826
    [Abstract] [Full Text] [Related]

  • 16. Tyrosine phosphorylation is an essential event in the stimulation of B lymphocytes by Staphylococcus aureus Cowan I.
    Roifman CM, Chin K, Gazit A, Mills GB, Gilon C, Levitzki A.
    J Immunol; 1991 May 01; 146(9):2965-71. PubMed ID: 1707926
    [Abstract] [Full Text] [Related]

  • 17. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F, Gao G, Wang LM, Landstrom TR, Degerman E, Pierce JH, Manganiello VC.
    J Immunol; 1999 Apr 15; 162(8):4864-75. PubMed ID: 10202031
    [Abstract] [Full Text] [Related]

  • 18. CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line.
    Wendtner CM, Schmitt B, Gruss HJ, Druker BJ, Emmerich B, Goodwin RG, Hallek M.
    Cancer Res; 1995 Sep 15; 55(18):4157-61. PubMed ID: 7545087
    [Abstract] [Full Text] [Related]

  • 19. Growth regulation of a human mature B cell line, B104, by anti-IgM and anti-IgD antibodies.
    Kim KM, Yoshimura T, Watanabe H, Ishigami T, Nambu M, Hata D, Higaki Y, Sasaki M, Tsutsui T, Mayumi M.
    J Immunol; 1991 Feb 01; 146(3):819-25. PubMed ID: 1988498
    [Abstract] [Full Text] [Related]

  • 20. Differential inhibition of T cell receptor signal transduction and early activation events by a selective inhibitor of protein-tyrosine kinase.
    Trevillyan JM, Lu YL, Atluru D, Phillips CA, Bjorndahl JM.
    J Immunol; 1990 Nov 15; 145(10):3223-30. PubMed ID: 2172380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.